Recent News View All News

Cellectar Provides Update on Phase 1 Trial of CLR 131 in Relapsed/Refractory Multiple Myeloma

January 7, 2019

Cellectar Biosciences to Present at the Biotech Showcase

January 3, 2019

View All News

Recent Events View IR Calendar

Biotech Showcase

Jan 7, 2019 • 10:00am PST

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up